OXC-BETA

Welcome to the Brand page for “OXC-BETA”, which is offered here for Adjuvants for use with vaccines; animal feed additives and supplements; anti-infective products for veterinary use; anti-inflammatories; dietary, nutritionals and food supplements; nutritional supplements for general health and well-being; dietary food supplements for general health and well-being; medicated dermatological preparations and substances; medicated skin care preparations; non-medicated additives for animal feed for use as nutritional supplements; nutritional supplements for supporting immune function; nutritional supplements for cats, dogs, horses, livestock; pharmaceutical preparations for treatment of infectious diseases, respiratory infections, eye infections; pharmaceutical preparations for animal skincare; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations and substances for the treatment of viral, respiratory, gastrointestinal, dermatological, and immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of bacteria-based diseases or disorders; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for skin care; pharmaceutical preparations for the treatment of bacterial infections; pharmaceutical preparations for the treatment of bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections; pharmaceutical preparations for the prevention and treatment of disorders of the immune system, pharmaceutical preparations for treatment of respiratory diseases, disorders and infections; pharmaceutical preparations for the treatment of inflammatory disorders and diseases, inflammatory bowel diseases, inflammatory connective tissue diseases; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in gastroenterology; pharmaceutical products for skin care for animals; pharmaceutical products for the treatment of joint disease; pharmaceutical products for treating respiratory diseases; veterinary preparations for treatment of intestinal bacteria; veterinary pharmaceutical preparations for animals and poultry to give newborn animals and birds a healthy start; veterinary pharmaceutical preparations for respiratory and reproductive diseases in cattle; veterinary pharmaceutical preparations for treatment of bacterial infections in dogs; veterinary pharmaceutical preparations for the treatment of infectious diseases in poultry; veterinary pharmaceutical preparations for treatment of infectious disease, respiratory infections, eye infections, topical infections; veterinary pharmaceutical preparations for the treatment of infectious diseases, swine dysentery, bacterial enteritis, bluecomb, pneumonia; veterinary pharmaceutical preparations for the treatment of swine bacterial infectious diseases; veterinary pharmaceutical preparations for treatment of intestinal bacteria;.

Its status is currently believed to be active. Its class is unavailable. “OXC-BETA” is believed to be currently owned by “AVIVAGEN INC.”